2024
Joint bleeds in mild hemophilia: Prevalence and clinical characteristics
Chiari J, Prozora S, Feinn R, Louizos E, Gallagher P, Bona R. Joint bleeds in mild hemophilia: Prevalence and clinical characteristics. Haemophilia 2024, 30: 331-335. PMID: 38240020, DOI: 10.1111/hae.14939.Peer-Reviewed Original ResearchMild haemophiliaJoint bleedsJoint range of motionHepatitis CRange of motionMild diseaseHistory of joint bleedsInstitutional review board approvalJoint rangeRetrospective chart reviewHemophilia treatment centersReview board approvalJoint healthHistory of traumaDisease burdenMedical recordsChart reviewClinical characteristicsMitigate disease burdenRisk factorsBoard approvalBleedingTraumatic bleedingAverage ageHemophilic arthropathy
2014
Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m2) – a Post-Hoc Sub-Analysis of the guardian™ Trials
Recht M, Lentz S, Zupancic-Šalek S, Matytsina I, Landorph A, Saugstrup T. Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m2) – a Post-Hoc Sub-Analysis of the guardian™ Trials. Blood 2014, 124: 1503. DOI: 10.1182/blood.v124.21.1503.1503.Peer-Reviewed Original ResearchNon-obese patientsGeneral healthJoint healthCenters for Disease Control and PreventionDisease Control and PreventionPrevalence of obesityOverall health statusControl and PreventionObese patientsAnalysis of prevalenceTuroctocog alfaHealth statusLonger life expectancyTime of enrollmentIncreased BMIHaemophilia carePost-hoc sub-analysisBMIHealthLife expectancyCo-morbidityClinical trial populationsFactor VIII doseObesityCardiovascular disease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply